Fuller & Thaler Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.87M | Buy |
|
|||||
|
2025
Q1 | $1.19M | Buy |
|
|||||
|
2024
Q4 | $1.04M | Buy |
|
|||||
|
2024
Q3 | $918K | Buy |
|
|||||
|
2024
Q2 | $911K | Buy |
|
|||||
|
2024
Q1 | $472K | Sell |
|
|||||
|
2023
Q4 | $569K | Buy |
|
|||||
|
2023
Q3 | $405K | Buy |
|
|||||
|
2023
Q2 | $420K | Buy |
|
|||||
|
2023
Q1 | $302K | Hold |
|
|||||
|
2022
Q4 | $301K | Sell |
|
|||||
|
2022
Q3 | $447K | Sell |
|
|||||
|
2022
Q2 | $454K | Sell |
|
|||||
|
2022
Q1 | $742K | Buy |
|
|||||
|
2021
Q4 | $821K | Sell |
|
|||||
|
2021
Q3 | $1.11M | Sell |
|
|||||
|
2021
Q2 | $1.46M | Sell |
|
|||||
|
2021
Q1 | $1.38M | Sell |
|
|||||
|
2020
Q4 | $1.43M | Buy |
|
|||||
|
2020
Q3 | $1.65M | Hold |
|
|||||
|
2020
Q2 | $1.55M | Buy |
|
|||||
|
2020
Q1 | $1.84M | Sell |
|
|||||
|
2019
Q4 | $3.61M | Buy |
|
|||||
|
2019
Q3 | $2.34M | Hold |
|
|||||
|
2019
Q2 | $2.35M | Buy |
|
|||||
|
2019
Q1 | $1.95M | Sell |
|
|||||
|
2018
Q4 | $3.04M | Sell |
|
|||||
|
2018
Q3 | $4.53M | Sell |
|
|||||
|
2018
Q2 | $4.62M | Hold |
|
|||||
|
2018
Q1 | $4.36M | Sell |
|
|||||
|
2017
Q4 | $5.26M | Sell |
|
|||||
|
2017
Q3 | $6.14M | Buy |
|
|||||
|
2017
Q2 | $5.22M | Sell |
|
|||||
|
2017
Q1 | $5.65M | Buy |
|
|||||
|
2016
Q4 | $5.15M | Buy |
|
|||||
|
2016
Q3 | $4.59M | Buy |
|
|||||
|
2016
Q2 | $2.76M | Sell |
|
|||||
|
2016
Q1 | $3.75M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $606K | Sell |
|
|||||
|
2015
Q1 | $971K | Buy |
|
|||||
|
2014
Q4 | $136K | Sell |
|
|||||
|
2014
Q3 | $7.14M | Buy |
|
|||||
|
2014
Q2 | $347K | Sell |
|
|||||
|
2014
Q1 | $1.13M | Buy |
|
|||||
|
2013
Q4 | $979K | Buy |
|
|||||
|
2013
Q3 | $698K | Sell |
|
|||||
|
2013
Q2 | $861K | Buy |
|